Hypogonadism Suspended Phase 2 Trials for Testosterone (DB00624)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Suspended2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01460654Testosterone and Alendronate in Hypogonadal MenTreatment